Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ELVN | Common Stock | 1.56M | Jun 2, 2022 | By entities affiliated with Pfizer Inc. | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ELVN | Stock Options (Right to Buy) | Award | $0 | +8.5K | $0.00 | 8.5K | Jun 2, 2022 | Common Stock | 8.5K | $1.07 | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person is Managing General Partner, Pfizer Ventures (US) LLC. The reporting person disclaims beneficial ownership of the shares owned by the entities affiliated with Pfizer Ventures (US) LLC except to the extent of her pecuniary interest therein. |
F2 | The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant. |